Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-10-078503
Filing Date
2010-04-07
Accepted
2010-04-07 16:58:04
Documents
3
Effectiveness Date
2010-04-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ddefa14a.htm DEFA14A 27169
2 GRAPHIC g35811g52w54.jpg GRAPHIC 8414
3 GRAPHIC g35811g89v18.jpg GRAPHIC 10346
  Complete submission text file 0001193125-10-078503.txt   54921
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-22873 | Film No.: 10737521
SIC: 2835 In Vitro & In Vivo Diagnostic Substances